Literature DB >> 28040601

A novel elastic liposome for skin delivery of papain and its application on hypertrophic scar.

Yan-Yan Chen1, Ye-Hui Lu2, Chun-Hua Ma3, Wei-Wei Tao3, Jing-Juan Zhu1, Xu Zhang4.   

Abstract

This study aims to investigate the therapeutic effects of papain elastic liposomes (PEL) on hypertrophic scar through topical application. PEL were prepared using the reverse-phase evaporation method and optimized by response surface methodology. The transdermal absorption of optimized PEL was tested by vertical Franz diffusion cells in vitro. The effects of PEL were investigated in rabbit model of hypertrophic scar in vivo, histological analysis and scar-related proteins were detected to reveal potential scar repair mechanism. The best formulation of PEL had EE (43.8±1.4%), particle size (100.9±2.2nm), PDI (0.037±0.003), zeta potential (-26.3±1.3mV), and DI (21.9±3.1). PEL gave the cumulative amounts and steady state fluxes in the receiver solution of 381.9±32.4μg/cm2, 11.4±1.5μg/cm2/h, and showed drug deposition in skin of 19.1±3.2% after 24h. After topical application, the scar elevation index, microvascular density, and collagen fiber were significantly decreased with regular arrangement. The expressions of TGF-β1, P-Smad-3, P-NF-κB p65, and P-IKBa in hypertrophic scar were significantly down regulated in contrast with those in model group. PEL were proven as an excellent topical preparation for hypertrophic scar treatment.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Elastic liposomes; Hypertrophic scar; Papain; Transdermal absorption

Mesh:

Substances:

Year:  2016        PMID: 28040601     DOI: 10.1016/j.biopha.2016.12.076

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Papain Loaded Poly(ε-Caprolactone) Nanoparticles: In-silico and In-Vitro Studies.

Authors:  Yasemin Budama-Kilinc; Rabia Cakir-Koc; Serda Kecel-Gunduz; Tolga Zorlu; Yagmur Kokcu; Bilge Bicak; Zeynep Karavelioglu; Aysen E Ozel
Journal:  J Fluoresc       Date:  2018-08-10       Impact factor: 2.217

Review 2.  Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.

Authors:  Fei Qu; Rui Geng; Yijing Liu; Jintao Zhu
Journal:  Theranostics       Date:  2022-04-11       Impact factor: 11.600

3.  Decreased expression of microRNA-145 promotes the biological functions of fibroblasts in hypertrophic scar tissues by upregulating the expression of transcription factor SOX-9.

Authors:  Shoujie Wang; Caiyun Li; Yijia Yu; Jianjun Qiao
Journal:  Exp Ther Med       Date:  2019-09-05       Impact factor: 2.447

Review 4.  Bio-Functional Textiles: Combining Pharmaceutical Nanocarriers with Fibrous Materials for Innovative Dermatological Therapies.

Authors:  Daniele Massella; Monica Argenziano; Ada Ferri; Jinping Guan; Stéphane Giraud; Roberta Cavalli; Antonello A Barresi; Fabien Salaün
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

Review 5.  Evidence-based therapy in hypertrophic scars: An update of a systematic review.

Authors:  Sebastian P Nischwitz; Katharina Rauch; Hanna Luze; Elisabeth Hofmann; Alexander Draschl; Petra Kotzbeck; Lars-Peter Kamolz
Journal:  Wound Repair Regen       Date:  2020-06-15       Impact factor: 3.617

6.  Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis.

Authors:  Jia Zhou; Yixuan Zhao; Vera Simonenko; John J Xu; Kai Liu; Deling Wang; Jingli Shi; Tianyi Zhong; Lixia Zhang; Lun Zeng; Bin Huang; Shenggao Tang; Alan Y Lu; A James Mixson; Yangbai Sun; Patrick Y Lu; Qingfeng Li
Journal:  Oncotarget       Date:  2017-09-14

7.  Biochemical Properties and Anti-Biofilm Activity of Chitosan-Immobilized Papain.

Authors:  Diana R Baidamshina; Victoria A Koroleva; Svetlana S Olshannikova; Elena Yu Trizna; Mikhail I Bogachev; Valeriy G Artyukhov; Marina G Holyavka; Airat R Kayumov
Journal:  Mar Drugs       Date:  2021-03-31       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.